Alzheimer's disease is a devastating disorder that strikes 1 in 10 Americans over age 65 and almost half of Americans over 85. The odds of developing Alzheimer's disease double every five years after age 65. While it is increasingly common to meet heart attack or cancer survivors, it is impossible to meet an Alzheimer's disease survivor because there are none. The Center of Excellence for Research on Complementary and Alternative Medicine (CERC) in Alzheimer's disease is a joint effort from investigators at Mount Sinai School of Medicine (MSSM), the Purdue University Botanical Research Center and collaborating institutions defines our vision for an integrated multidisciplinary program of preclinical research projects all linked by a unifying scientific theme related to the understanding of the potential protective roles of grape-derived polyphenols in Alzheimer's disease. There is mounting evidence that grape-derived polyphenols may beneficially influence Alzheimer's disease. However, because polyphenolic compositions and bioactivities vary considerably due to plant-growth environments, there are problems with the preparation of grape-derived polyphenols (and other dietary polyphenols). These limitations have prompted us to assemble groups of interdisciplinary scientists with expertise in Alzheimer's disease and nutritional-botanical sciences to design a series of studies with the ultimate goal of isolating and identifying, from dietary grape sources, bioactive and bioavailable polyphenolic compounds that are capable of providing beneficial Alzheimer's disease-modifying activities. Significant discoveries on the beneficial role of dietary polyphenolics in the prevention of Alzheimer's disease through the attenuation of (3-amyloid pathogenesis is providing new knowledge in novel pathogenic mechanisms and the possibility of novel potential solutions. The studies and the information that would be gleaned from this proposal are precisely on target to provide these insights. We are confident that the information that will come from this work will have a major impact on protective roles of grapederived polyphenols in Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Program Projects (P01)
Project #
5P01AT004511-04
Application #
7924674
Study Section
Special Emphasis Panel (ZAT1-SM (07))
Program Officer
Hopp, Craig
Project Start
2007-09-30
Project End
2012-09-29
Budget Start
2010-09-30
Budget End
2011-09-29
Support Year
4
Fiscal Year
2010
Total Cost
$1,543,704
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Pasinetti, Giulio Maria; Wang, Jun; Ho, Lap et al. (2015) Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Biochim Biophys Acta 1852:1202-8
Ho, Lap; Ferruzzi, Mario G; Janle, Elsa M et al. (2013) Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J 27:769-81
Wang, Jun; Tang, Cheuk; Ferruzzi, Mario G et al. (2013) Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model. Mol Nutr Food Res 57:2091-102
Capiralla, Hemachander; Vingtdeux, Valerie; Zhao, Haitian et al. (2012) Resveratrol mitigates lipopolysaccharide- and A*-mediated microglial inflammation by inhibiting the TLR4/NF-*B/STAT signaling cascade. J Neurochem 120:461-72
Wang, Jun; Ferruzzi, Mario G; Ho, Lap et al. (2012) Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci 32:5144-50
Santa-Maria, Ismael; Varghese, Merina; Ksiezak-Reding, Hanna et al. (2012) Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. J Biol Chem 287:20522-33
Blount, Jack W; Ferruzzi, Mario; Raftery, Dan et al. (2012) Enzymatic synthesis of substituted epicatechins for bioactivity studies in neurological disorders. Biochem Biophys Res Commun 417:457-61
Santa-Maria, Ismael; Diaz-Ruiz, Carmen; Ksiezak-Reding, Hanna et al. (2012) GSPE interferes with tau aggregation in vivo: implication for treating tauopathy. Neurobiol Aging 33:2072-81
Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian et al. (2011) Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-* peptide degradation. FASEB J 25:219-31
Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian et al. (2011) Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis. Mol Med 17:1022-30

Showing the most recent 10 out of 24 publications